The stock of Alphatec Holdings Inc (NASDAQ:ATEC) is a huge mover today! About 131,679 shares traded hands. Alphatec Holdings Inc (NASDAQ:ATEC) has risen 97.02% since March 4, 2016 and is uptrending. It has outperformed by 88.98% the S&P500.
The move comes after 9 months positive chart setup for the $58.00M company. It was reported on Oct, 7 by Barchart.com. We have $12.11 PT which if reached, will make NASDAQ:ATEC worth $35.38M more.
Analysts await Alphatec Holdings Inc (NASDAQ:ATEC) to report earnings on November, 1.
Alphatec Holdings Inc (NASDAQ:ATEC) Ratings Coverage
Out of 2 analysts covering Alphatec Holdings Inc. (NASDAQ:ATEC), 0 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 0 are positive. Alphatec Holdings Inc. has been the topic of 3 analyst reports since August 5, 2015 according to StockzIntelligence Inc. The rating was downgraded by Zacks to “Hold” on Friday, August 7. The firm has “Underperform” rating by Northland Capital given on Monday, March 14. Canaccord Genuity downgraded Alphatec Holdings Inc (NASDAQ:ATEC) rating on Wednesday, August 5. Canaccord Genuity has “Hold” rating and $1 price target.
According to Zacks Investment Research, “Alphatec Holdings, Inc. is a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. The Company’s principal product offering includes a variety of spinal implant products and systems consisted of components, such as spine screws and rods, spinal spacers, plates, and various biologics offerings. Alphatec Holdings, Inc. is headquartered in Carlsbad, California.”
Insitutional Activity: The institutional sentiment increased to 0.67 in Q2 2016. Its up 0.51, from 0.16 in 2016Q1. The ratio increased, as 8 funds sold all Alphatec Holdings Inc shares owned while 4 reduced positions. 3 funds bought stakes while 5 increased positions. They now own 14.37 million shares or 6.30% less from 15.34 million shares in 2016Q1.
Renaissance Technologies Ltd reported 1.05M shares or 0% of all its holdings. Royal Fincl Bank Of Canada reported 50,651 shares or 0% of all its holdings. Goldman Sachs Gru reported 102,485 shares or 0% of all its holdings. Financial Bank Of New York Mellon has invested 0% of its portfolio in Alphatec Holdings Inc (NASDAQ:ATEC). Morgan Stanley accumulated 0% or 75,826 shares. The California-based Blackrock Fund has invested 0% in Alphatec Holdings Inc (NASDAQ:ATEC). Pacwest Finance Management has 0.02% invested in the company for 96,775 shares. Deutsche State Bank Ag, a Germany-based fund reported 1,250 shares. Moreover, California Pub Employees Retirement System has 0% invested in Alphatec Holdings Inc (NASDAQ:ATEC) for 107,400 shares. The Illinois-based Guggenheim Cap Ltd Liability has invested 0% in Alphatec Holdings Inc (NASDAQ:ATEC). Stepstone Gru Lp has invested 0.58% of its portfolio in Alphatec Holdings Inc (NASDAQ:ATEC). Wesbanco Commercial Bank has 10,000 shares for 0% of their US portfolio. Deerfield Mngmt accumulated 0.07% or 4.98M shares. The California-based Wells Fargo Co Mn has invested 0% in Alphatec Holdings Inc (NASDAQ:ATEC). Spark Inv Mgmt Ltd Liability Company holds 263,500 shares or 0.01% of its portfolio.
More recent Alphatec Holdings Inc (NASDAQ:ATEC) news were published by: Reuters.com which released: “BRIEF-Alphatec Holdings announces one-for-twelve reverse stock split” on August 24, 2016. Also Globenewswire.com published the news titled: “Alphatec Spine Introduces New Titanium-Coated PEEK Interbody Fusion System” on October 12, 2015. Streetinsider.com‘s news article titled: “Globus Medical (GMED) to Acquire Alphatec International Business in $80M Deal” with publication date: July 26, 2016 was also an interesting one.
ATEC Company Profile
Alphatec Holdings, Inc., incorporated on March 4, 2005, is a medical technology company. The Firm through its subsidiary, Alphatec Spine, Inc. and its subsidiaries (Alphatec Spine), designs, develops, makes and markets products for the surgical treatment of spine disorders. The Company’s product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. The Company’s principal product offerings are focused on the global market for fusion spinal disorder solutions. The Company’s products include Cervical and Cervico-Thoracic Products; Thoracolumbar Fixation Products; Spinal Spacers; minimally invasive surgery (MIS) Products, and Biologics.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.